SMN2 and proximal spinal muscular atrophy: Since our statewide implementation in January 2018, our use of a sequencing assay and its modification for SMN2 copy-number analysis has facilitated the early referral and universal access to supplemental information used by specialists in the diagnosis and treatment of infants with SMA.